CUPROPHANE BUT NOT SYNTHETIC MEMBRANE INDUCES INCREASES IN SERUM TUMOR-NECROSIS-FACTOR-ALPHA LEVELS DURING HEMODIALYSIS

被引:64
作者
CANIVET, E [1 ]
LAVAUD, S [1 ]
WONG, T [1 ]
GUENOUNOU, M [1 ]
WILLEMIN, JC [1 ]
POTRON, G [1 ]
CHANARD, J [1 ]
机构
[1] CHU REIMS, HOP MAISON BLANCHE, SERV NEPHROL, HEMATOL LAB, F-51092 REIMS, FRANCE
关键词
CYTOKINE; TUMOR NECROSIS FACTOR-ALPHA; HEMODIALYSIS; DIALYSIS MEMBRANE; ENDOTOXIN;
D O I
10.1016/S0272-6386(12)80810-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cytokine synthesis and secretion by blood mononuclear cells is a well-documented phenomenon in hemodialyzed patients. The present study was conducted in 17 chronically hemodialyzed patients to test the relative effect of uremic toxicity, membrane biocompatibility, dialysate composition, and the risk of endotoxinemia on the serum level of tumor necrosis factor-alpha (TNF-α). The only significant parameter that influenced circulating TNF-α was the chemical characteristics of the dialyzer membrane. Tumor necrosis factor-alpha levels significantly increased during the session with cuprophane, whereas they decreased with AN69. The TNF-α increase was documented whatever the dialysate buffer and the presence or absence (negative Limulus amoebocyte lysate test) of endotoxin in the dialysate. In the subgroup of patients treated with a contaminated dialysate and AN69, none had clinical symptoms and the central body temperature remained constant throughout the session. In these patients, serum TNF-α levels did not change after priming the dialyzer with sterile saline. In conclusion, the serum TNF-α level during hemodialysis appears to be modulated by biocompatibility, permeability, and binding properties of dialysis membrane rather than dialysate composition. Endotoxin in the dialysate did not result in positive TNF-α balance no matter what its possible priming effect on mononucleated blood cells. © 1994, National Kidney Foundation. All rights reserved.. All rights reserved.
引用
收藏
页码:41 / 46
页数:6
相关论文
共 42 条
[1]   STABILIZATION OF THE BIOACTIVITY OF TUMOR-NECROSIS-FACTOR BY ITS SOLUBLE RECEPTORS [J].
ADERKA, D ;
ENGELMANN, H ;
MAOR, Y ;
BRAKEBUSCH, C ;
WALLACH, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :323-329
[2]   CUPRAMMONIUM MEMBRANES STIMULATE INTERLEUKIN-1 RELEASE AND ARACHIDONIC-ACID METABOLISM IN MONOCYTES IN THE ABSENCE OF COMPLEMENT [J].
BETZ, M ;
HAENSCH, GM ;
RAUTERBERG, EW ;
BOMMER, J ;
RITZ, E .
KIDNEY INTERNATIONAL, 1988, 34 (01) :67-73
[3]   CONTROL OF CACHECTIN (TUMOR-NECROSIS-FACTOR) SYNTHESIS - MECHANISMS OF ENDOTOXIN RESISTANCE [J].
BEUTLER, B ;
KROCHIN, N ;
MILSARK, IW ;
LUEDKE, C ;
CERAMI, A .
SCIENCE, 1986, 232 (4753) :977-980
[4]   HIGH-PERMEABLE MEMBRANES AND HYPERSENSITIVITY-LIKE REACTIONS - ROLE OF DIALYSIS FLUID CONTAMINATION [J].
BIGAZZI, R ;
ATTI, M ;
BALDARI, G .
BLOOD PURIFICATION, 1990, 8 (04) :190-198
[5]  
BINGEL M, 1987, LANCET, V1, P14
[6]   RECOMBINANT C5A ENHANCES INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR RELEASE BY LIPOPOLYSACCHARIDE-STIMULATED MONOCYTES AND MACROPHAGES [J].
CAVAILLON, JM ;
FITTING, C ;
HAEFFNERCAVAILLON, N .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (02) :253-257
[7]   TUMOR-NECROSIS-FACTOR DOES NOT INCREASE DURING ROUTINE CUPROPHANE HEMODIALYSIS IN HEALTHY WELL-NOURISHED PATIENTS [J].
DAVENPORT, A ;
CRABTREE, J ;
ANDROJNA, C ;
WILL, EJ ;
DAVISON, AM .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1991, 6 (06) :435-439
[8]  
DINARELLO CA, 1992, KIDNEY INT, V42, pS68
[9]   CYTOKINES - AGENTS-PROVOCATEURS IN HEMODIALYSIS [J].
DINARELLO, CA ;
HARRINGTON, JT ;
KING, A ;
KASSIRER, JP ;
LEVEY, AS ;
MEYER, K ;
KURTIN, P ;
GELFAND, J ;
PEREIRA, BJG ;
SINGH, A .
KIDNEY INTERNATIONAL, 1992, 41 (03) :683-694
[10]  
ENGELMANN H, 1990, J BIOL CHEM, V265, P1531